|Bid||51.75 x 800|
|Ask||53.86 x 4000|
|Day's Range||52.13 - 53.16|
|52 Week Range||49.31 - 86.31|
|Beta (3Y Monthly)||0.65|
|PE Ratio (TTM)||9.91|
|Earnings Date||Jun 27, 2019|
|Forward Dividend & Yield||1.76 (3.57%)|
|1y Target Est||57.90|
The U.S. economy added just 75,000 jobs in May, with unemployment holding steady at 3.6%. Joe Song, Bank of America U.S. Economist, along with Andrew Levin, Professor of Economics at Dartmouth College, join Seana Smith on 'The Ticker' to discuss.
The Dow Jones Industrial Average has gained nearly 12% so far in 2019. It doesn't seem like a whole heck of a lot, but considering the topsy-turvey markets of 2019, it's a pretty strong lift. That gain was driven by the majority of the Dow 30 as most of the stocks in the DJIA index contributed to its postive year-to-date gain.Microsoft (NASDAQ:MSFT) is the biggest winner of the bunch, gaining more than 30%. But owing to the odd price-weighted nature of the index, it's likely Visa (NYSE:V), with a 28% gain and a higher share price, that has been the biggest driver behind the Dow's gains.Not every component of the Dow Jones today has had a strong year, though. Five of the index's 30 stocks have declined so far this year. But not all of them make the list of the five worst Dow Jones stocks in 2019, which we'll recount in greater detail going forward.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Top-Rated Biotech Stocks to Invest In Today For reasons that go beyond pure performance, these five components have had the roughest year so far, which means they have the most to prove in the second half of 2019. Walgreens (WBA)Source: Mike Mozart via FlickrWalgreens (NASDAQ:WBA) is the easiest pick on the list. That's somewhat ironic considering that Walgreens is one of the index's newest members, replacing General Electric (NYSE:GE) just last year. WBA stock far and away has had the worst performance in 2019: its 22.6% decline is almost exactly twice as steep as that of the index's second-biggest decliner. WBA touched a five-year low late last month before a modest rally in recent weeks.As I wrote in April, disappointing store-level execution clearly has been a factor. But what might be more worrisome for WBA is that the entire retail pharmacy industry seems to under threat. Shares of rival CVS Health (NYSE:CVS), too, have touched a multi-year low.Smaller Rite Aid (NYSE:RAD) continues to plunge, with a hefty debt load adding to the pressure. Front-end sales aren't growing, and in pharmacy higher generic prices are compressing already-thin margins.WBA stock is cheap, now at less than 9x forward earnings. But right now, Walgreens looks a lot like most other retailers - and that will have to change for Walgreens stock to reverse its performance in not only 2019, but the last few years. Dow Inc. (DOW)Source: Roy Luck via Flickr (modified)It's a little unfair to put Dow Inc. (NYSE:DOW) on this list. DOW shares actually have gained 6% since they were spun off from what is now (again) DuPont (NYSE:DD) on April 1st.But DOW is part of the DowDuPont spinoff, a hugely complicated financial engineering project that was supposed to create real value for shareholders. It hasn't happened. DWDP shareholders received one share of Corteva (NYSE:CTVA) and one share of DOW for every three DowDuPont shares they owned. At current prices, that totals about $50 in value. DWDP shares closed 2018 near $54 - after declining 25% last year.This was a case where many value investors saw significant upside. Yet trade war concerns and post-spin trading have led DWDP to destroy value, at least so far. DOW and its former siblings still have time, and room, to rally. But a lot of smart investors likely see the YTD performance as among the most disappointing in their portfolios. Intel (INTC)Source: Shutterstock Performance-wise, Intel (NASDAQ:INTC) hasn't been a bad stock in 2019. It's underperformed the market, but a 0.5% decline actually turns very slightly positive when accounting for dividend payments.Still, 2019 hasn't been a good year for Intel. It's suffering chip shortages. It's still behind in 10nm -- and about four years late. Rival Advanced Micro Devices (NASDAQ:AMD) is gobbling up market share in CPUs. Apple (NASDAQ:AAPL) settled with Qualcomm (NASDAQ:QCOM) in large part because Intel couldn't move quick enough to get the iPhone to 5G.Intel still is a behemoth in the chip space, and the company still has time to right its ship. With INTC stock at barely 10x earnings, there's upside if and when that happens. But the company's performance so far this year inspires little confidence, which has been much weaker than a flattish stock price would imply. 3M (MMM)Source: Shutterstock The 11.4% decline in 3M (NYSE:MMM) shares so far this year is the second-worst performance in the Dow. But no component has posted a worse quarterly report than 3M did with its Q1 release in late April. 3M stock plunged 13%, its worst one-day decline in over 30 years. The drop was big enough to on its own pull the index down over 100 points.MMM stock still hasn't recovered: it would drop nearly another 20% in the following weeks before bottoming of late. And there's a case for the stock after the big decline, as James Brumley argued earlier this month. A 3.4% dividend yield helps the argument, and 3M's diversified business should allow it to ride out any further near-term or market volatility.Still, Q1 was an obvious concern: stocks like 3M don't fall 25% in a matter of weeks for no reason. And it was the automotive and Chinese markets that led to the poor quarter. Neither seems likely to rebound sharply all that soon. At the very least, it's going to take a lot more than one good quarter for 3M to make back what it lost after Q1. Pfizer (PFE)Source: Shutterstock It's a bit unfair to put Pfizer (NYSE:PFE) on this list. Pfizer certainly hasn't had a terrible year. PFE stock is down 2.6%, the third-worst performance in the index. But drugmakers generally underperform in bull markets, and many drug stocks have done worse in 2019. A 3.4% dividend yield offsets most of those losses anyhow.That said, Pfizer hasn't had a great year, either. Rival (and fellow Dow component) Merck (NYSE:MRK) has gained 8%-plus. And it's hard not to get the sense that PFE, which traded mostly sideways for over three years in the middle of the decade, is back to being stagnant. There doesn't seem to much of a catalyst on the horizon to change the Pfizer story, while external pressures on the industry continue to mount.It's true that, even this year, PFE shareholders could have done worse. But given that 25 Dow Jones stocks are up YTD, it's obvious they could have done better.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * The 7 Best Tech Stocks to Buy for the Second Half of 2019 * 7 Top-Rated Biotech Stocks to Invest In Today * 4 Semiconductor Stocks to Sell Compare Brokers The post The 5 Worst Dow Jones Stocks So Far in 2019 appeared first on InvestorPlace.
Walgreens opened Monday at $52.57 with a loss of 23.1% year to date and in bear market territory 39.1% below its Dec. 4 intraday high of $86.31. The stock's weekly slow stochastic reading ended last week at 8.03, well below 10.00, making the stock technically "too cheap to ignore." Walgreens is also fundamentally cheap with a P/E ratio of 8.66 and a dividend yield of 3.33%, according to Macrotrend. Walgreens is in a period of transformation from being just a pharmacy chain to offering services to help cancer patients.
Walgreens and Greater Than AIDS are working with health departments, HIV/AIDS service organizations, and other community organizations to provide free HIV testing and information at select Walgreens stores in more than 260 cities on National HIV Testing Day (NHTD), Thursday, June 27 between 10 am – 7 pm (local time). HIV testing is recommended as part of routine health care, yet many Americans are not being tested as often as advised. According to the Centers for Disease Control and Prevention (CDC), one in seven people living with HIV in the U.S. today are unaware of their status.
Walgreens Boots Alliance Inc NASDAQ/NGS:WBAView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is low for WBA with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative but appears to be improving. Over the last one-month, outflows of investor capital in ETFs holding WBA totaled $272 million. However, outflows appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managersâ€™ Index (PMI) data, output in the Consumer Servicesis falling. The rate of decline is significant relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Overall, the first quarter has been relatively strong for retailers, so let's look at what investors should expect from Kroger to see if they should consider buying KR stock heading into its Q1 earnings release.
Women feel guilty about taking time for self-care, and many say their responsibility to take care of others is the reason.
With more than 2,700 branded locations nationwide, this grocer plans to introduce topical CBD products in a third of all states.
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $52.12, marking a -1.44% move from the previous day.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Walgreens Boots Alliance, Inc. New York, June 12, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Walgreens Boots Alliance, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Kroger Co (NYSE: KR ) is the latest company to introduce CBD products to its U.S. store shelves. The grocery chain's corporate affairs manager for its Michigan division, Rachel Hurst, said the company ...
Over the last year, shares of FedEx (NYSE:FDX) are down nearly 40%, opening for trade June 7 near $157 each. The reason can be summed up in one word: Amazon (NASDAQ:AMZN).Source: Shutterstock The growth of what is now the country's second-leading retailer (after Walmart (NYSE:WMT)) continues to make traders quake in their blue suede shoes. (That's your reminder that FedEx is based in Memphis.)You can buy FedEx today for less than 12 times last year's earnings and get a $2.60 per share dividend that yields 1.69%. The market cap is now $41 billion, against 2018 revenue of $65.5 billion.InvestorPlace - Stock Market News, Stock Advice & Trading TipsYou may have to wait for the market to wake up, but your patience should be rewarded. FDX Stock Is Still GrowingDespite any appearance to the contrary, FedEx continues to grow.FedEx is due to report its fourth quarter on June 25. Analysts are expecting earnings of $4.89 per share on revenue of $18.04 billion. * 7 S&P 500 Dividend Stocks to Buy at Least Yielding 3% That would put revenue for the full year at $69 billion, about $4 billion ahead of last year. It would more than cover the dividend and could spark a hike.Investors were spooked by a miss on the third quarter, earnings falling 7 cents short of estimates at $3.03 per share. CEO Fred Smith admitted they were below expectations, blaming the company's investments in network infrastructure and automation.He also could have blamed TNT Express, acquired for $4.8 billion in 2016. Integration costs on the European-based company were 21 cents per share. Matching Amazon StockBut the stock has since fallen below the level it was at after those earnings came out.The reason for that is Amazon, which continues to make headlines with things like drone delivery, its own hub airport in Kentucky, along with expansions in Rockford, Illinois, and Lakeland, Florida ,There's one thing wrong with this picture, as it relates to FedEx. That is, Amazon infrastructure serves AMZN stock, and its re-sellers. Amazon may have half the e-commerce market, but that still leaves half that's not Amazon, and there is more to delivery than e-commerce.It is more reasonable to be concerned about whether the trade war will kick FedEx out of China, or the cost of expanding ground service, or how managers might react to the end of cash bonuses.If anyone should worry about Amazon, and its knock-on effects in the delivery business, it should be the U.S. Postal Service. They just lost FedEx' SmartPost business. FedEx' expansion of Ground delivery to Sunday, matching Amazon, means it's entering a niche that had been keeping the USPS competitive.FedEx is also working closely with Amazon rivals like Walmart and Walgreens (NYSE:WBA) on next-day delivery. It's even turning Target (NYSE:TGT) stores into local shipment hubs, matching a deal Amazon recently signed with Kohl's (NYSE:KSS).Wherever Amazon innovates in delivery, FedEx does too, keeping its service competitive on behalf of all of Amazon's competitors. Economically it's a win-win. The Bottom LineBecause Amazon's recent innovations are all on the fast side of delivery, long considered FedEx' niche, the impact on FedEx stock has been twice what it was on that of rival UPS (NYSE:UPS), down 15% over the last year.Trade war fears have exacerbated that fear.As the old saying goes, when the going gets tough the tough get going. That doesn't mean the tough abandon the field. It means they compete harder. That's what FedEx is doing, and the whole economy is the beneficiary.At its current levels, given its continuing profitability and investments in the business, it's hard to see FedEx as anything but a buy for a long-term investor.Dana Blankenhorn is a financial and technology journalist. He is the author of a new environmental story, Bridget O'Flynn and the Bear, available now at the Amazon Kindle store. Write him at firstname.lastname@example.org or follow him on Twitter at @danablankenhorn. As of this writing he owned shares in AMZN. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 S&P 500 Dividend Stocks to Buy at Least Yielding 3% * 7 Stocks to Buy That Don't Care About Tariffs * 5 Healthcare Stocks to Pick Up From the Wreckage Compare Brokers The post Fear of Amazon Creates a Bargain in FedEx Stock appeared first on InvestorPlace.
A market surge in the first quarter, spurred by easing global macroeconomic concerns and Powell's pivot ended up having a positive impact on the markets and many hedge funds as a result. The stocks of smaller companies which were especially hard hit during the fourth quarter slightly outperformed the market during the first quarter. Unfortunately, […]
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $50.98, marking a +0.35% move from the previous day.
Walgreens Boots (WBA) is diligently trying to redress specific areas of operational weakness and enhancing its managerial skills for a better operating performance.
The Zacks Analyst Blog Highlights: General Electric, Anthem, Northrop Grumman, Walgreens and Honda
The Geo Group, Vista Outdoor, CVS and Walgreens Boots Alliance highlighted as Zacks Bull and Bear of the Day